Firm Analyst Phone E-Mail
Brean Murray Jonathan  Aschoff 212.702.6652 aschoffj@bmur.com
Burrill & Co. Reni  Benjamin, Ph.D. 415.591.5435 rbenjamin@b-c.com
Dawson James Securities Michael  G  King, Jr. 212.750.7291 mking@djsiny.com
JMP Securities Jason  N  Butler 212.906.3505 jbutler@jmpscurities.com
Ladenburg Thalmann Matt  Kaplan 212.891.5247 mkaplan@ladenburg.com
MLV & Co Ed  Arce 646.556.9203 earce@mlvco.com
Oppenheimer Boris  Peaker 212.667.8564 boris.peaker@opco.com
Roth Capital Joseph  Pantginis 646.358.1907 jpantginis@roth.com
Stifel Nicolaus Stephen  Willey 212.271.3620 swilley@stifel.com

Keryx Biopharmaceuticals, Inc. is followed by the analyst(s) listed above. Please note that any opinions, estimates or forecasts regarding Keryx Biopharmaceuticals, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Keryx Biopharmaceuticals, Inc. or its management. Keryx Biopharmaceuticals, Inc. does not by the reference to the analysts above imply its endorsement of or concurrence with any information, conclusions or recommendations made by such analysts


Copyright © 2013 by Keryx Biopharmaceuticals, Inc.
Update Notice | Disclaimer | Contact Us